Cunnane, Stephen C. http://orcid.org/0000-0003-4003-9762
Trushina, Eugenia http://orcid.org/0000-0002-6291-2860
Morland, Cecilie http://orcid.org/0000-0002-1776-1821
Prigione, Alessandro http://orcid.org/0000-0001-9457-1952
Casadesus, Gemma
Andrews, Zane B. http://orcid.org/0000-0002-9097-7944
Beal, M. Flint
Bergersen, Linda H.
Brinton, Roberta D.
de la Monte, Suzanne
Eckert, Anne http://orcid.org/0000-0002-9341-3669
Harvey, Jenni
Jeggo, Ross
Jhamandas, Jack H. http://orcid.org/0000-0002-4688-6500
Kann, Oliver http://orcid.org/0000-0003-4365-8067
la Cour, Clothide Mannoury
Martin, William F. http://orcid.org/0000-0003-1478-6449
Mithieux, Gilles
Moreira, Paula I. http://orcid.org/0000-0001-5177-6747
Murphy, Michael P. http://orcid.org/0000-0003-1115-9618
Nave, Klaus-Armin http://orcid.org/0000-0001-8724-9666
Nuriel, Tal
Oliet, Stéphane H. R.
Saudou, Frédéric http://orcid.org/0000-0001-6107-1046
Mattson, Mark P. http://orcid.org/0000-0002-9816-4155
Swerdlow, Russell H.
Millan, Mark J.
Article History
Accepted: 3 June 2020
First Online: 24 July 2020
Competing interests
: S.C.C. declares that he has consulted for and has received honoraria, test products and/or research funding from Abitec, Accera, Bulletproof, Nestlé and Servier, is the founder of Senotec and is co-inventor on a patent for a medium chain triglyceride formulation. M.J.M. declares that he is a full-time employee of Servier and has no other interests to declare. M.P.M. declares that he holds patents related to therapies targeted at decreasing oxidative damage to mitochondria. G.C. declares that she holds a patent related to compositions and methods for treating cognitive deficits using amylin and other hormones. A.E. declares that she has received honoraria, test products and/or research funding from Schwabe and Vifor. F.S. declares that he has consulted for Servier and TEVA. R.D.B. declares that she holds patents for therapeutics targeting Alzheimer disease and neurodegenerative disorders of ageing and is the founder of NeuTherapeutics. E.T. declares that she holds a patent related to compositions and methods for treating cognitive deficit using complex I inhibitors. All other authors declare no competing interests.